Search peptides, terms, sources/
Research source · 2024

Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
Subgroups of adults with primary mitochondrial myopathy from the MMPOWER-3 trial
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Post hoc subgroup analysis after a trial that did not meet its primary endpoint. It generates hypotheses and does not confirm a benefit. The abstract gives no total sample size. Abstract read via Europe PMC; full text not read.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.